Showing 39,681 - 39,700 results of 101,327 for search '(( 5 ((((nn decrease) OR (we decrease))) OR (a decrease)) ) OR ( 5 point decrease ))', query time: 1.88s Refine Results
  1. 39681

    Experimental desensitization of the Rb-E2F switch to serum by a Cdk2 inhibitor drug. by Tae J. Lee (241477)

    Published 2010
    “…<p>(A) E2F activity, measured by the GFP signal in the E2F-d2GFP cells, was assayed under varying concentrations of Cdk2 inhibitor CVT-313 (0.5, 1, 2, 3, and 5 µM) and serum (0.2%, 0.3%, 0.5%, 0.7%, 1.0%, 2.0%). …”
  2. 39682

    Supplementary Material for: Accelerated Venovenous Hemofiltration as a Transitional Renal Replacement Therapy in the Intensive Care Unit by Allegretti A.S. (8489511)

    Published 2020
    “…We examined AVVH as a transition therapy between CRRT and iHD, with the aim of decreasing time on CRRT and providing a more graduated transition for hemodynamically unstable patients requiring RRT. …”
  3. 39683
  4. 39684

    A Systematic Review of the Robson Classification for Caesarean Section: What Works, Doesn't Work and How to Improve It by Ana Pilar Betrán (2155669)

    Published 2014
    “…This classification has become very popular over the last years in many countries. We conducted a systematic review to synthesize the experience of users on the implementation of this classification and proposed adaptations.…”
  5. 39685

    Data_Sheet_1_Nimodipine vs. Milrinone – Equal or Complementary Use? A Retrospective Analysis.pdf by Jennifer Jentzsch (13042506)

    Published 2022
    “…Only nimodipine or the combined approach could prevent DCI-related infarction (both 57.1%), not milrinone alone (87.5%). Both drugs induced a doubled vasopressor demand due to blood pressure decrease, but milrinone alone induced tachycardia.…”
  6. 39686

    Text S1 - Niclosamide Is a Proton Carrier and Targets Acidic Endosomes with Broad Antiviral Effects by Andreas Jurgeit (125389)

    Published 2012
    “…<b>Figure S5.</b> Niclosamide is an early and reversible inhibitor of HRV1A, 2, 14 and 16 infections.…”
  7. 39687

    SCP-induced inhibition of PVN neurons is prevented by a selective CRF-R2 antagonist. by Chun-Ping Chu (287953)

    Published 2013
    “…B, Antisauvagine-30, a selective CRF-R2 antagonist (30 nM), did not affect the evoked spike firing of the neuron (upper), but abolished the SCP-induced decrease in spike firing (lower). …”
  8. 39688

    Influence of Interface Engineering of the Water Oxidation Electrocatalyst and One-to-One Advantages: High Intrinsic Activity and Solar to Hydrogen Conversion Efficiency by Dhanasingh Thiruvengadam (18775314)

    Published 2025
    “…The distinctive morphology of Co<sub>4</sub>Ni<sub>2</sub>CPs exhibits a competitive overpotential in GC and NF (301 and 241 mV, respectively), and a smaller Tafel slope (60 and 56 mV dec<sup>–1</sup>, respectively) than IrO<sub>2</sub> (351 and 301 mV; 76 and 74 mV dec<sup>–1</sup>, respectively). …”
  9. 39689
  10. 39690

    Effects of exposure to large sharks on the abundance and behavior of mobile prey fishes along a temperate coastal gradient by Brendan D. Shea (8582076)

    Published 2020
    “…These modifications were underscored by a decrease in smooth dogfish abundance in areas of high exposure as well. …”
  11. 39691
  12. 39692
  13. 39693

    Effects of Secondary Anions on Proton Conduction in a Flexible Cationic Phosphonate Metal–Organic Framework by Daniel A. Levenson (8266386)

    Published 2020
    “…Impedance analysis showed a clear decrease in proton conductivity after the loss of the halides, more pronounced in the bromide-containing structures.…”
  14. 39694

    Effects of Secondary Anions on Proton Conduction in a Flexible Cationic Phosphonate Metal–Organic Framework by Daniel A. Levenson (8266386)

    Published 2020
    “…Impedance analysis showed a clear decrease in proton conductivity after the loss of the halides, more pronounced in the bromide-containing structures.…”
  15. 39695

    <i>Varroa</i> model validation: Mid-season data. by Alison McAfee (1392388)

    Published 2024
    “…While the prevalence of diseases vary according to regional and seasonal patterns, the influence of specific climatic predictors has rarely been formally assessed. To address this gap, we analyzed how occurrence and intensity of three prominent honey bee disease agents (<i>Varroa destructor</i> ― hereon <i>Varroa</i> ― <i>Melissococcus plutonius</i>, and <i>Vairimorpha</i> spp.) varied according to regional, temporal, and climatic factors in honey bee colonies across five Canadian provinces that were sampled at three time points. …”
  16. 39696

    <i>Varroa</i> model validation: Full-season data. by Alison McAfee (1392388)

    Published 2024
    “…While the prevalence of diseases vary according to regional and seasonal patterns, the influence of specific climatic predictors has rarely been formally assessed. To address this gap, we analyzed how occurrence and intensity of three prominent honey bee disease agents (<i>Varroa destructor</i> ― hereon <i>Varroa</i> ― <i>Melissococcus plutonius</i>, and <i>Vairimorpha</i> spp.) varied according to regional, temporal, and climatic factors in honey bee colonies across five Canadian provinces that were sampled at three time points. …”
  17. 39697
  18. 39698
  19. 39699
  20. 39700